Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (10): 834-839    DOI: 10.19485/j.cnki.issn2096-5087.2023.10.002
  论著 本期目录 | 过刊浏览 | 高级检索 |
动脉粥样硬化性心血管疾病高危人群血脂控制达标的影响因素研究
黄文1, 何亮2, 傅玲娟3, 翁丽霞4, 张馨锡5, 朱淑霞6, 张阳辉7, 陈奇峰1
1.绍兴市疾病预防控制中心慢性非传染性疾病预防控制所,浙江 绍兴 312000;
2.诸暨市疾病预防控制中心,浙江 诸暨 311800;
3.柯桥区疾病预防控制中心,浙江 绍兴 312030;
4.嵊州市疾病预防控制中心,浙江 嵊州 312400;
5.上虞区疾病预防控制中心,浙江 绍兴 312300;
6.越城区疾病预防控制中心,浙江 绍兴 312000;
7.新昌县疾病预防控制中心,浙江 新昌 312500
Factors affecting blood lipid control among residents at a high risk of atherosclerotic cardiovascular disease
HUANG Wen1, HE Liang2, FU Lingjuan3, WENG Lixia4, ZHANG Xinxi5, ZHU Shuxia6, ZHANG Yanghui7, CHEN Qifeng1
1. Department of Non-communicable Chronic Diseases Control and Prevention, Shaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang 312000, China;
2. Zhuji Center for Disease Control and Prevention, Zhuji, Zhejiang 311800, China;
3. Keqiao District Center for Disease Control and Prevention, Shaoxing, Zhejiang 312030, China;
4. Shengzhou Center for Disease Control and Prevention, Shengzhou, Zhejiang 312400, China;
5. Shangyu District Center for Disease Control and Prevention, Shaoxing, Zhejiang 312300, China;
6. Yuecheng District Center for Disease Control and Prevention, Shaoxing, Zhejiang 312000, China;
7. Xinchang County Center for Disease Control and Prevention, Xinchang, Zhejiang 312500, China
全文: PDF(760 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解动脉粥样硬化性心血管疾病(ASCVD)高危人群血脂控制达标情况及其影响因素,为制订ASCVD高危人群血脂管理措施提供依据。方法 于2021年5—7月,采用多阶段整群抽样方法从绍兴市6个县(市、区)抽取35~70岁ASCVD高危人群为研究对象。通过问卷调查收集人口学信息、吸烟、饮酒和慢性病史等;测量身高、体重、腰围和血压;检测总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和空腹血糖;分析血脂控制达标率,并采用多因素logistic回归模型分析血脂控制达标的影响因素。结果 纳入ASCVD高危人群1 695人,其中男性940人,占55.46%,女性755人,占44.54%;年龄为(62.56±6.08)岁。血脂控制达标285人,达标率为16.81%。多因素logistic回归分析结果显示,性别(男,OR=1.962,95%CI:1.396~2.758)、年龄(OR=1.037,95%CI:1.013~1.061)、腰围(OR=0.979,95%CI:0.964~0.995)、舒张压(OR=0.981,95%CI:0.967~0.994)、吸烟(OR=1.485,95%CI:1.034~2.133)、饮酒(OR=0.684,95%CI:0.498~0.941)、高血压(OR=1.428,95%CI:1.006~2.207)和服用降糖药物(OR=2.326,95%CI:1.720~3.144)是ASCVD高危人群血脂控制达标的影响因素。结论 ASCVD高危人群中,腰围较大、舒张压较高和饮酒者血脂控制达标率较低,男性、年龄较大、患高血压和服用降糖药物者血脂控制达标率较高。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
黄文
何亮
傅玲娟
翁丽霞
张馨锡
朱淑霞
张阳辉
陈奇峰
关键词 动脉粥样硬化性心血管疾病高危人群血脂控制心血管疾病    
AbstractObjective To investigate the proportion of achieving the blood lipid control target and its influencing factors among residents at a high risk of atherosclerotic cardiovascular disease (ASCVD), so as to provide insights into management of blood lipid among residents at a high risk of ASCVD. Methods Residents at a high risk of ASCVD and at ages of 35 to 70 years were sampled using a multi-stage cluster sampling method from 6 counties (districts) in Shaoxing City from May to July 2021. The residents' demographics, smoking, alcohol consumption and medical history of chronic diseases were collected using questionnaires, the height, weight, waist circumference (WC) and blood pressure were measured, and the total cholesterol (TC), triacylglycerol (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and fasting blood glucose were detected. The proportion of blood lipids achieving the control target was analyzed, and factors affecting the proportion of blood lipids achieving the control target were identified using a multivariable logistic regression model. Results A total of 1 695 individuals at a high risk of ASCVD were enrolled, including 940 men (55.46%) and 755 women (44.54%), with a mean age of (62.56±6.08) years. There were 285 participants that achieved the target of blood lipid control (16.81%). Multivariable logistic regression analysis identified gender (male, OR=1.962, 95%CI: 1.396-2.758), age (OR=1.037, 95%CI: 1.013-1.061), WC (OR=0.979, 95%CI: 0.964-0.995), diastolic blood pressure (OR=0.981, 95%CI: 0.967-0.994), smoking (OR=1.485, 95%CI: 1.034-2.133), alcohol consumption (OR=0.684, 95%CI: 0.498-0.941), hypertension (OR=1.428, 95%CI: 1.006-2.207), administration of hypoglycemic drugs (OR=2.326, 95%CI: 1.720-3.144) as factors affecting the achievement of the target for blood lipid control among residents at a high risk of ASCVD. Conclusion Individuals at a high risk of ASCVD with higher WC, higher diastolic blood pressure and alcohol consumption are less likely to achieve the target for blood lipid control, while male individuals with older age, hypertension and administration of hypogcemic drugs are more likely to achieve the target for blood lipid control.
Key wordshigh-risk population of atherosclerotic cardiovascular disease    blood lipid control    cardiovascular disease
收稿日期: 2023-05-31      修回日期: 2023-08-27      出版日期: 2023-10-10
中图分类号:  R589.2  
基金资助:绍兴市级医卫类科技计划项目(2020A13058)
通信作者: 陈奇峰,E-mail:cqf5899@163.com   
作者简介: 黄文,硕士,主管医师,主要从事慢性病预防控制工作
引用本文:   
黄文, 何亮, 傅玲娟, 翁丽霞, 张馨锡, 朱淑霞, 张阳辉, 陈奇峰. 动脉粥样硬化性心血管疾病高危人群血脂控制达标的影响因素研究[J]. 预防医学, 2023, 35(10): 834-839.
HUANG Wen, HE Liang, FU Lingjuan, WENG Lixia, ZHANG Xinxi, ZHU Shuxia, ZHANG Yanghui, CHEN Qifeng. Factors affecting blood lipid control among residents at a high risk of atherosclerotic cardiovascular disease. Preventive Medicine, 2023, 35(10): 834-839.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.10.002      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I10/834
[1] 国家心血管病中心.中国心血管健康与疾病报告2021[M].北京:科学出版社,2022.
[2] FERENCE B A,GINSBERG H N,GRAHAM I,et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease.1.evidence from genetic,epidemiologic,and clinical studies.a consensus statement from the European Atherosclerosis Society Consensus Panel[J].Eur Heart J,2017,38(32):2459-2472.
[3] 赵冬. 中国人群血脂异常流行趋势和治疗控制现状[J].中华心血管病杂志,2019,47(5):341-343.
[4] 张洁,何青芳,王立新,等.浙江省成年人血脂异常知晓率、治疗率和控制率的影响因素分析[J].预防医学,2020,32(12):1230-1235.
[5] 中国血脂管理指南修订联合专家委员会.中国血脂管理指南(2023年)[J].中国循环杂志,2023,38(3):237-271.
[6] MACH F,BAIGENT C,CATAPANO A L,et al.2019 ESC/EAS guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk[J].Eur Heart J,2020,41(1):111-188.
[7] GRUNDY S M,STONE N J,BAILEY A L,et al.2018 HA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].Circulation,2019,139(25):1082-1143.
[8] ZHANG M,DENG Q,WANG L,et al.Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults:a nationally representative survey of 163 641 adults[J].Int J Cardiol,2018,260:196-203.
[9] 中华医学会.血脂异常基层诊疗指南(实践版2019)[J].中华全科医师杂志,2019,18(5):417-421.
[10] 胡如英,王勇,陈凯伦,等.浙江省农村2型糖尿病患者血脂水平及控制现状[J].预防医学,2019,31(11):1091-1096.
[11] 朱梓嫣,郑频频.国内外大学生吸烟行为研究进展[J].健康教育与健康促进,2017,12(2):110-113.
[12] World Health Organization.International guide for monitoring alcohol consumption and related harm[R].Geneva:WHO,2022.
[13] 任雪英. 女性绝经前后性激素与血脂水平变化的临床分析[J].中国妇幼保健,2013,28(30):4986-4987.
[14] 赵冉,韩辉,于春晓,等.绝经后2型糖尿病患者性激素水平和血脂及内脏脂肪面积的关系[J].中华内分泌代谢杂志,2019,35(11):950-954.
[15] 黄绮娴,温燕婷,黄俊,等.社区老年居民血脂异常患病率及其影响因素研究[J].中国全科医学,2023,26(28):3520-3525.
[16] 中国毒理学会临床毒理专业委员会,中国老年保健医学研究会老年内分泌与代谢病分会.老年人多重用药安全管理专家共识[J].中国全科医学,2018,21(29):3533-3544.
[17] SITTIWET C,SIMONEN P,GYLLING H,et al.Mortality and cholesterol metabolism in subjects aged 75 years and older:the Helsinki businessmen study[J].J Am Geriatr Soc,2020,68(2):281-287.
[18] 苏健,向全永,吕淑荣,等.成年人体质指数、腰围与高血压、糖尿病和血脂异常的关系[J].中华疾病控制杂志,2015,19(7):696-700.
[19] 刘婧慧. 吉林省心血管高危人群行为变化轨迹的影响因素及与心血管事件关系研究[D].长春:吉林大学,2022.
[20] 黄文,汤佳良,陈康康,等.绍兴市心血管疾病高危人群危险因素聚集分析[J].预防医学,2023,35(4):298-302,330.
[21] 邓丽丽,赵晓彤,陈明卫.二甲双胍降糖外作用的最新研究进展[J].中国综合临床,2019,35(6):572-576.
[22] 中华医学会心血管病学分会高血压学组.中国高血压患者血压血脂综合管理的专家共识[J].中华心血管病杂志,2021,49(6):554-563.
[23] 李勇,赵水平,叶平,等.中国血脂异常门诊患者调脂治疗一级和二级预防达标现状:DYSIS-China亚组分析[J].中华心血管病杂志,2016,44(8):665-670.
[1] 黄文, 汤佳良, 陈康康, 黄敏钢, 陈奇峰. 绍兴市心血管疾病高危人群危险因素聚集分析[J]. 预防医学, 2023, 35(4): 298-302,330.
[2] 林永兴, 刘足云, 李娜, 于村. 1990—2019年浙江省心血管疾病负担变化趋势[J]. 预防医学, 2022, 34(10): 1020-1025.
[3] 赵瑞, 黄胜楠, 肖暖. 中等强度有氧运动预防高胆固醇血症患者动脉粥样硬化性心血管疾病效果评价[J]. 预防医学, 2022, 34(1): 58-62.
[4] 韩雅斌, 陈向宇, 钟节鸣, 方乐, 梁明斌, 谢开婿, 张晓怡, 曹元, 陆凤, 徐春晓, 林静静. 桐乡市老年人群心血管疾病危险因素暴露及聚集分析[J]. 预防医学, 2021, 33(8): 812-814.
[5] 向静, 赵廷明, 李鑫, 张劲. 通江县35~75岁居民心血管疾病高危人群调查[J]. 预防医学, 2021, 33(6): 609-614.
[6] 蒙家嘉, 李辉, 王永, 纪威, 冯伟, 张瑞洁, 刘杨, 刘世炜, 韩丽媛. 2009—2018年宁波市居民心血管疾病死亡及早死所致疾病负担趋势分析[J]. 预防医学, 2021, 33(5): 451-456.
[7] 陈欢, 刘永生,尹扬光. PM2.5对动脉粥样硬化的影响及机制[J]. 预防医学, 2021, 33(10): 1017-1021.
[8] 胡如英, 王勇, 陈凯伦, 何青芳, 潘劲. 浙江省农村2型糖尿病患者血脂水平及控制现状[J]. 预防医学, 2019, 31(11): 1091-1096.
[9] 汤晓菲,马志红. 航天系统职工血脂异常情况调查[J]. 预防医学, 2018, 30(9): 939-942.
[10] 杜美丽, 钟爱芳. 心血管健康管理电话干预效果评价[J]. 预防医学, 2017, 29(5): 527-529,532.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed